Brasil | Artículos de revistas
dc.creatorda Silva Melo, P
dc.creatorDurán, N
dc.creatorHaun, M
dc.date2000-Aug
dc.date2015-11-27T12:22:40Z
dc.date2015-11-27T12:22:40Z
dc.date.accessioned2018-03-29T00:54:21Z
dc.date.available2018-03-29T00:54:21Z
dc.identifierToxicology Letters. v. 116, n. 3, p. 237-42, 2000-Aug.
dc.identifier0378-4274
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/10996486
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/194586
dc.identifier10996486
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1294819
dc.descriptionThe cytotoxicity of prodigiosin, an antibiotic and potential trypanocide produced by Serratia marcescens, and Benznidazole, a trypanocidal drug, were assayed on V79 fibroblast cell line. Three independent endpoints for cytotoxicity were evaluated; namely, the nucleic acid content (NAC), MTT reduction and neutral red uptake (NRU). IC(50) values of 1-20 microM were obtained for prodigiosin in the NRU, MTT and NAC tests. Prodigiosin had greater trypanocidal activity (IC(50)=5 microM) than Nifurtimox (IC(50)=150 microM) a known trypanocide drug used in Chagas' disease therapy. Benznidazole was less toxic (IC(50)=2000 microM) than prodigiosin (IC(50)=1-20 microM) in V79 cells based on the MTT and NAC assays. Benznidazole stimulated the NRU until 2 mM. Indeed, the cell viability measured with the NRU was higher at all concentrations of benznidazole tested than that measured by MTT reduction and NAC assays.
dc.description116
dc.description237-42
dc.languageeng
dc.relationToxicology Letters
dc.relationToxicol. Lett.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAnimals
dc.subjectCell Survival
dc.subjectCells, Cultured
dc.subjectCricetinae
dc.subjectCricetulus
dc.subjectDose-response Relationship, Drug
dc.subjectNitroimidazoles
dc.subjectProdigiosin
dc.subjectTrypanocidal Agents
dc.titleCytotoxicity Of Prodigiosin And Benznidazole On V79 Cells.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución